期刊文献+
共找到44篇文章
< 1 2 3 >
每页显示 20 50 100
天然沸石合成A型分子筛的吸附与再生特性 被引量:14
1
作者 孙彤 郝瑞霞 +2 位作者 武旭源 李嘉雯 李鹏 《中国环境科学》 EI CAS CSCD 北大核心 2020年第7期2926-2933,共8页
针对污水厂尾水深度脱氮问题,以某地产天然沸石为原料,采用水热合成法制备了纯度较高、晶型规整、大小均一、吸附量大的A型分子筛.系统考察了其对氨氮的吸附及再生特性,并结合Zeta电位、FTIR以及XRD对其氨氮吸附与再生机理进行了分析.... 针对污水厂尾水深度脱氮问题,以某地产天然沸石为原料,采用水热合成法制备了纯度较高、晶型规整、大小均一、吸附量大的A型分子筛.系统考察了其对氨氮的吸附及再生特性,并结合Zeta电位、FTIR以及XRD对其氨氮吸附与再生机理进行了分析.结果表明:准一级和准二级反应动力学均能较好地反映A型分子筛吸附氨氮过程,等温吸附过程符合Langmuir等温吸附模型,对氨氮的最大饱和吸附量为41.68mg/g;吸附饱和的分子筛再生利用方法简便易行,经2mol/L NaCl溶液解吸后能够恢复其吸附能力,5次吸附-解吸再生率均在95%以上;其吸附与再生过程均为Na^+与NH4^+的离子交换反应,吸附与再生互为可逆过程.该方法为污水厂深度脱氮提供了一条经济可行的新思路. 展开更多
关键词 吸附 氨氮 A型分子筛 机理 再生
下载PDF
冠心病患者血浆脂蛋白磷脂酶A2水平与脂蛋白亚组分的相关性研究 被引量:13
2
作者 吴亚茹 王君 +7 位作者 徐瑞霞 张彦 李小林 李莎 郭远林 董倩 刘庚 李建军 《中国分子心脏病学杂志》 CAS 2019年第1期2742-2747,共6页
目的探讨稳定型冠心病(CAD)患者血浆脂蛋白磷脂酶A2 (Lp-PLA2)与脂蛋白亚组分的相关性。方法连续入选未服用降脂药物治疗的受试人群324例(其中CAD患者253例,非CAD 71例),收集临床资料,采用ELISA方法检测血浆Lp-PLA2水平、Lipoprint脂蛋... 目的探讨稳定型冠心病(CAD)患者血浆脂蛋白磷脂酶A2 (Lp-PLA2)与脂蛋白亚组分的相关性。方法连续入选未服用降脂药物治疗的受试人群324例(其中CAD患者253例,非CAD 71例),收集临床资料,采用ELISA方法检测血浆Lp-PLA2水平、Lipoprint脂蛋白分类检测仪分析低密度脂蛋白(LDL)和高密度脂蛋白(HDL)亚组分。结果与非CAD相比,CAD患者血浆LpPLA2水平较高(153.61±78.73 vs 131.41±65.49 ng/ml, P=0.028)。单因素变量分析表明,CAD患者血浆Lp-PLA2水平与大颗粒、中等颗粒及小颗粒LDL-C浓度均呈正相关(r=0.213,P=0.001;r=0.353,P<0.001; r=0.187,P=0.003),与LDL颗粒大小呈负相关(r=0.140,P=0.026);血浆Lp-PLA2水平与小颗粒HDL-C浓度呈正相关(r=0.180, P=0.004),而与大颗粒和中等颗粒HDL-C浓度呈负相关(r=0.133, P=0.034; r=0.154, P=0.014),然而在非CAD人群并无相关性。经多因素回归分析调整传统危险因素后,CAD患者血浆Lp-PLA2水平与各大小颗粒的LDL-C浓度以及小颗粒HDL-C浓度仍呈独立正相关(β=0.263,P<0.001;β=0.327, P<0.001;β=0.135, P=0.033;β=0.133, P=0.034)。结论稳定型冠心病患者血浆Lp-PLA2水平不仅与LDL-C浓度及LDL-C各亚组分相关,且与小颗粒HDL-C具有相关性,提示Lp-PLA2与脂蛋白亚组分表型分布可能存在潜在相互作用。 展开更多
关键词 稳定型冠心病 血浆脂蛋白磷脂酶A2 LDL亚组分 HDL亚组分
原文传递
Safety and Necessity of Antiplatelet Therapy on Patients Underwent Endovascular Aortic Repair with Both Stanford Type B Aortic Dissection and Coronary Heart Disease 被引量:10
3
作者 rui-xia He Lei Zhang +6 位作者 Tie-Nan Zhou Wen-Jie yuan Yan-Jie Liu Wen-xia Fu Quan-Min Jing Hai-Wei Liu xiao-Zeng Wang 《Chinese Medical Journal》 SCIE CAS CSCD 2017年第19期2321-2325,共5页
Background: Acute aortic dissection is known as the most dangerous aortic disease, with management and prognosis determined as the disruption of the medial layer provoked by intramural bleeding. The objective of this... Background: Acute aortic dissection is known as the most dangerous aortic disease, with management and prognosis determined as the disruption of the medial layer provoked by intramural bleeding. The objective of this study was to evaluate the safety and necessity of antiplatelet therapy on patients with Stanford Type B aortic dissection (TBAD) who underwent endovascular aortic repair (EVAR). Methods: The present study retrospectively analyzed 388 patients with TBAD who underwent EVAR and coronary angiography. The primary outcomes were hemorrhage, death, endoleak, recurrent dissection, myocardial infarction, and cerebral infarction in patients with and without aspirin antiplatelet therapy at 1 month and 12 months. Results: Of those 388 patients, 139 (35.8%) patients were treated with aspirin and 249 (64.2%) patients were not treated with aspirin. Patients in the aspirin group were elderly (57.0 ± 10.3 years vs. 52.5 ± 11.9 years, respectively, χ2 = 3.812, P 〈 0.001) and had more hypertension (92.1% vs. 83.9%, respectively, χ2 = 5.191, P = 0.023) and diabetes (7.2% vs. 2.8%, respectively, χ2 = 4.090, P = 0.043) than in the no-aspirin group. Twelve patients (aspirin group vs. no-aspirin group; 3.6% vs. 2.8%, respectively, χ2 = 0.184, P = 0.668) died at 1-month follow-up, while the number was 18 (4.6% vs. 5.0%, respectively, χ2 = 0.027, P = 0.870) at 12-month follow-up. Hemorrhage occurred in 1 patient (Bleeding Academic Research Consortium [BARC] Type 2) of the aspirin group, and 3 patients (1 BARC Type 2 and 2 BARC Type 5) in the no-aspirin group at 1-month follow-up ( χ2 = 0.005, P = 0.944). New hemorrhage occurred in five patients in the no-aspirin group at 12-month follow-up. Three patients in the aspirin group while five patients in the no-aspirin group had recurrent dissection for endoleak at 1-month follow-up (2.3% vs. 2.2%, respectively, χ2 = 0.074, P = 0.816). Four patients had new dissection in the no-aspirin group at 12-month follow-up � 展开更多
关键词 Acute Coronary Syndrome: Antiplatelet AorticDissection Endovascular Aortic Repair
原文传递
河北沧州饮水中碘氟含量差异地区儿童甲状腺结节的检出情况 被引量:7
4
作者 闫瑞霞 周媛 +8 位作者 李彦国 许蕊 李淑贞 温松臣 李晓梅 张丽萍 孟羽俊 任建立 刘明清 《环境与职业医学》 CAS CSCD 北大核心 2019年第5期470-473,478,共5页
[背景]甲状腺结节的检出率高达19%~68%。现已公认饮水碘含量过高或缺乏均可造成甲状腺形态和功能的损害。但饮水氟与碘双重因素对甲状腺形态和功能的影响,各地的研究结果不一致。[目的]本研究拟通过调查河北省沧州市饮水中不同碘、氟含... [背景]甲状腺结节的检出率高达19%~68%。现已公认饮水碘含量过高或缺乏均可造成甲状腺形态和功能的损害。但饮水氟与碘双重因素对甲状腺形态和功能的影响,各地的研究结果不一致。[目的]本研究拟通过调查河北省沧州市饮水中不同碘、氟含量地区儿童甲状腺结节检出情况,为探讨环境中碘、氟含量是否与儿童甲状腺结节发生有关提供基础数据。[方法]采用多级分层整群抽样的方法,分别在沧州市的单纯高碘、低碘、碘正常、高碘高氟(分为3个亚组)、低碘高氟地区,选择具有中小学的1~2个行政村,以在当地出生并持续居住在本地的8~15岁学龄儿童为对象,采用彩色多普勒超声检查其甲状腺结节的情况。[结果]共调查儿童1859人,其中女生933人,男生926人。单纯高碘地区248人、低碘地区216人、碘正常地区316人、高碘高氟地区737人、低碘高氟地区342人。8~10岁儿童869人,11~15岁990人。不同地区儿童家中无碘盐率为77.9%~97.6%。单纯高碘、低碘、碘正常三个地区比较:8~10岁及11~15岁儿童甲状腺结节检出率均无差异(χ^2=4.270,P=0.118;χ^2=5.506,P=0.064);同一地区,11~15岁与8~10岁儿童甲状腺结节检出率无差异(χ^2=0.299,P=0.584;χ^2=0.000,P=1.000;χ^2=0.240,P=0.878)。不同高碘高氟亚组间8~10岁及11~15岁儿童甲状腺结节检出率的差异有统计学意义(χ^2=37.933,P<0.0001;χ^2=27.385,P<0.0001),两年龄组甲状腺结节检出率均在高碘高氟1区最高(23.08%,29.82%)。低碘高氟地区与单纯低碘地区比较:8~10岁儿童甲状腺结节检出率两地区之间差异无统计学意义(χ^2=1.907,P=0.167),但11~15岁儿童甲状腺结节检出率前者(7.44%)高于后者(1.75%)(χ^2=4.721,P=0.030);同一地区,两年龄组儿童甲状腺结节检出率之间无差异(χ^2=0.235,P=0.627;χ^2=1.390,P=0.238)。[结论]河北省沧州市饮水中氟含量正常、碘含量不同地区8~15岁儿童甲状腺结节检出率没� 展开更多
关键词 饮用水 甲状腺结节 儿童
原文传递
金凤丸联合重组人生长激素改善薄型子宫内膜不孕患者子宫内膜容受性 被引量:7
5
作者 刘珊 解凯辉 +4 位作者 魏蕊霞 从幸 冯晓晔 吴园园 杨波 《国际生殖健康/计划生育杂志》 CAS 2021年第2期93-97,共5页
目的:观察中成药金凤丸联合重组人生长激素(rhGH)对薄型子宫内膜不孕患者子宫内膜容受性的临床疗效。方法:收集2018年12月—2019年12月在中国人民解放军联勤保障部队第九八〇医院生殖医学科就诊的薄型子宫内膜合并不孕患者80例,采用金... 目的:观察中成药金凤丸联合重组人生长激素(rhGH)对薄型子宫内膜不孕患者子宫内膜容受性的临床疗效。方法:收集2018年12月—2019年12月在中国人民解放军联勤保障部队第九八〇医院生殖医学科就诊的薄型子宫内膜合并不孕患者80例,采用金凤丸联合rhGH预处理的薄型子宫内膜不孕患者(40例)作为观察组;仅常规处理者作为对照组(40例)。比较2组患者的子宫内膜厚度、子宫内膜分型、子宫内膜下血流分型、临床妊娠率及早期流产率。结果:2组患者取卵年龄、不孕时间、体质量指数(BMI)、基础卵泡刺激素(FSH)、胚胎移植数目、移植胚胎情况及治疗前子宫内膜形态分型、子宫内膜下血流、内膜厚度比较,差异均无统计学意义(均P>0.05)。观察组移植日子宫内膜厚度高于对照组,A型及B型子宫内膜患者妊娠率高于C型子宫内膜患者,Ⅱ型及Ⅲ型子宫内膜血流患者妊娠率高于Ⅰ型子宫内膜血流患者,差异均有统计学意义(P<0.05)。观察组临床妊娠率高于对照组,而流产率低于对照组,差异有统计学意义(P<0.05)。结论:金凤丸联合rhGH可以改善薄型子宫内膜不孕患者的子宫内膜容受性,进而提高临床妊娠率,改善妊娠结局。 展开更多
关键词 中成药 生长激素 子宫内膜 胚胎移植 局部血流
下载PDF
天然沸石定向合成A型分子筛及其脱氮性能 被引量:7
6
作者 孙彤 郝瑞霞 +2 位作者 武旭源 李嘉雯 李鹏 《中国环境科学》 EI CAS CSCD 北大核心 2020年第2期623-630,共8页
针对污水厂尾水深度脱氨问题,以河南巩义的天然沸石为起始原料,采用常压水热合成方法,选用4种不同的工艺方案合成A型分子筛,并对合成产物的吸附氨氮性能及其纯度、晶体结构、形貌特征、孔隙率等材料结构特征进行分析与表征,探讨天然沸... 针对污水厂尾水深度脱氨问题,以河南巩义的天然沸石为起始原料,采用常压水热合成方法,选用4种不同的工艺方案合成A型分子筛,并对合成产物的吸附氨氮性能及其纯度、晶体结构、形貌特征、孔隙率等材料结构特征进行分析与表征,探讨天然沸石制备高效脱氨分子筛的合成方法.结果表明:与直接碱溶法制备硅源相比,碱熔融活化法对沸石原料硅的利用率较高,硅源纯化合成方案产物的氨氮吸附性能显著得到改善,平衡吸附量达20mg/g以上;其晶体形貌规整有序、杂质含量低、孔道通畅,有利于吸附扩散与传质过程.综合考虑硅源制备能耗、物耗及合成产物吸附性能,天然沸石合成A型分子筛适宜的工艺方案为碱溶纯化合成法. 展开更多
关键词 天然沸石 A型分子筛 水热合成 吸附 氨氮
下载PDF
金凤丸辅助治疗首次行冻融胚胎解冻移植术不孕症患者的临床效果观察 被引量:5
7
作者 刘珊 从幸 +4 位作者 魏蕊霞 解凯辉 冯晓晔 吴园园 杨波 《临床误诊误治》 2020年第11期47-52,共6页
目的观察金凤丸辅助治疗首次行冻融胚胎解冻移植术不孕症患者的临床效果。方法选取行首次冻融胚胎解冻移植术的不孕症200例,根据不同治疗方法将其分为观察组和对照组两组各100例,观察组常规内膜准备过程中应用金凤丸,对照组仅常规内膜... 目的观察金凤丸辅助治疗首次行冻融胚胎解冻移植术不孕症患者的临床效果。方法选取行首次冻融胚胎解冻移植术的不孕症200例,根据不同治疗方法将其分为观察组和对照组两组各100例,观察组常规内膜准备过程中应用金凤丸,对照组仅常规内膜准备未应用金凤丸。观察比较两组子宫内膜准备过程中雌二醇(E 2)、黄体生成激素(LH)及孕酮水平,内膜情况及移植胚胎情况,子宫内膜下血流分型,临床结局,以及子宫内膜形态分型与妊娠关系、治疗期间不良反应发生情况。结果子宫内膜准备过程中两组自然周期、促排卵周期排卵日E 2、LH、孕酮水平和人工周期内膜转化日E 2、孕酮水平比较差异均无统计学意义(P>0.05)。观察组线型内膜明显多于对照组,子宫内膜下血流较对照组丰富,临床妊娠率和胚胎种植率高于对照组,差异均有统计学意义(P<0.05或P<0.01)。临床妊娠率线型内膜患者高于非线型内膜患者,差异有统计学意义(P<0.01)。两组治疗期间均未发生明显不良反应。结论金凤丸辅助治疗首次行冻融胚胎解冻移植术不孕症患者能改善子宫内膜容受性,进而提高临床妊妊娠率和胚胎种植率。 展开更多
关键词 不育 女(雌)性 胚胎移植 金凤丸 子宫内膜 临床妊娠
下载PDF
血浆前蛋白转化酶枯草杆菌蛋白酶kexin 9型水平与冠状动脉钙化的关系 被引量:5
8
作者 曹晔萱 赵肸 +12 位作者 张惠雯 李莎 张彦 徐瑞霞 朱成刚 吴娜琼 郭远林 卿平 李小林 刘庚 董倩 孙静 李建军 《中国循环杂志》 CSCD 北大核心 2018年第2期134-137,共4页
目的:探讨血浆前蛋白转化酶枯草杆菌蛋白酶kexin 9型(PCSK9)水平与冠状动脉钙化(CAC)的关系。方法:连续入选未接受降脂治疗的因胸痛就诊的患者380例,均接受计算机断层摄影术扫描,并测量CAC积分。CAC积分>0分患者为CAC组(n=156),CAC积... 目的:探讨血浆前蛋白转化酶枯草杆菌蛋白酶kexin 9型(PCSK9)水平与冠状动脉钙化(CAC)的关系。方法:连续入选未接受降脂治疗的因胸痛就诊的患者380例,均接受计算机断层摄影术扫描,并测量CAC积分。CAC积分>0分患者为CAC组(n=156),CAC积分=0分患者为非CAC组(n=224)。再将CAC组根据CAC积分进一步分为三个亚组,CAC积分=1~100分亚组(n=53),CAC积分=101~400分亚组(n=64),CAC积分>400分亚组(n=39)。收集临床资料,测定血浆PCSK9水平。对血浆PCSK9水平与CAC积分之间的关系进行统计学分析。结果:CAC组患者血浆PCSK9水平显著高于非CAC组[(260.23±69.34)ng/ml vs(205.46±53.21)ng/ml,P<0.001]。三个CAC积分亚组的PCSK9水平分别为CAC积分=1~100分亚组:(247.38±72.68)ng/ml;CAC积分=101~400分亚组:(264.87±57.63)ng/ml;CAC积分>400分亚组:(295.33±69.06)ng/ml。随着CAC积分增加,各亚组血浆PCSK9水平逐步升高,差异均有统计学意义(P均<0.05)。经多因素回归分析,调整传统心血管危险因素后证实,PCSK9水平与CAC呈正相关(β=0.584,P=0.002)。此外,血浆PCSK9预测CAC最佳临界值为228.58 ng/ml,敏感性67%,特异性71%。结论:血浆PCSK9水平与CAC之间呈正相关。 展开更多
关键词 前蛋白转化酶类 冠状动脉钙化
下载PDF
基于科研需求调查的医学信息服务方式探索 被引量:3
9
作者 黄文生 刘瑞霞 +6 位作者 古想花 李立 高远 王金合 李中伟 杜丽萍 丰锐 《医药论坛杂志》 2022年第12期31-34,共4页
目的基于河南省地市级三级医院临床医务人员科研活动需求的调查,探索高效医学信息服务方式。方法根据前期对河南省部分地市级三级医院临床医务人员的科研现状、信息需求行为及信息服务开展情况的调研分析,针对其科研信息需求行为,提出... 目的基于河南省地市级三级医院临床医务人员科研活动需求的调查,探索高效医学信息服务方式。方法根据前期对河南省部分地市级三级医院临床医务人员的科研现状、信息需求行为及信息服务开展情况的调研分析,针对其科研信息需求行为,提出个性化、精准、可行的服务方式并进行实施。结果①建立线上科研培训平台,聘请专家进行线上系统的科研及信息利用等培训讲座;②建立科研微信群,共享最新科学研究进展或指南;③不定期、个性化、精准推送学科研究热点;④指导有科研意向人员与院内(外)高水平专家、团队合作,快速提升其科研能力;⑤举办线下系统科研培训讲座或医学信息专业人员多节点、分时段深入到医院科室,进行现场讲解、交流互动,面对面解答临床医务人员有关科研活动中的困惑及难题;⑥医学信息专业人员分批、分区域定点派驻医院,作为高水平专家、科研管理人员、临床医务人员之间沟通的桥梁和纽带。结论通过多种医学信息服务方式的探索,为精准化、个性化服务医院、服务基层,促进科学技术创新和人才培养,推动河南省卫生健康事业高质量发展及进一步挖掘医学情报部门服务临床一线的潜能,拓展医学信息服务模式,提供了有价值的参考及实践验证。 展开更多
关键词 河南省 科研活动 医学信息 服务方式
原文传递
EDTA interfacial chelation Ca^(2+) incorporates superhydrophobic coating for scaling inhibition of CaCO_(3) in petroleum industry 被引量:4
10
作者 Ming-Liang Zhu Hui-Juan Qian +3 位作者 rui-xia yuan Dong-Yan Zhao Hai-Chao Huang Huai-yuan Wang 《Petroleum Science》 SCIE CAS CSCD 2021年第3期951-961,共11页
In this paper,the superhydrophobic poly(vinylidene fuoride)/fuorinated ethylene propylene/SiO_(2)/CNTs-EDTA(PFSCEDTA)composite coating was successfully fabricated and applied for anti-scaling performance.The depositio... In this paper,the superhydrophobic poly(vinylidene fuoride)/fuorinated ethylene propylene/SiO_(2)/CNTs-EDTA(PFSCEDTA)composite coating was successfully fabricated and applied for anti-scaling performance.The deposition of CaCO_(3) on the surface of the superhydrophobic PFSC-EDTA composite coating reached 0.0444 mg/cm^(2) for 192-h immersion into the supersaturated CaCO_(3) solution,which was only 11.4%that of the superhydrophobic PFSC composite coating.At the interface between the CaCO_(3) solution and the PFSC-EDTA coating,the Ca^(2+)could be frstly chelated by EDTA that was beneft for improving the anti-scaling performance of the superhydrophobic PFSC-EDTA composite coating.In another hand,the addition of EDTA to the CNTs played an important role in fabricating the SiO_(2)-centric and CNTs-EDTA-surrounded multilevel micro-nanostructure in the superhydrophobic PFSC-EDTA composite coating,in favor of maintaining the air flm under the water and the stability of the superhydrophobic surface.The research supplies a new way of improving antiscaling performance of superhydrophobic coating by incorporating the organic chelating agent at the interface and changing the traditional way of scale prevention. 展开更多
关键词 ANTI-SCALING Superhydrophobic coating EDTA Poly(vinylidene fuoride) Carbon nanotubes
下载PDF
A Smart Molecule Showing Spin Crossover Responsive Aggregation-Induced Emission
11
作者 Cheng Yi Yin-Shan Meng +7 位作者 Liang Zhao Nian-Tao Yao Qiang Liu Wen Wen rui-xia Li yuan-yuan Zhu Hiroki Oshio Tao Liu 《CCS Chemistry》 CSCD 2023年第4期915-924,共10页
The utilization of spin crossover(SCO)to modulate the luminescence properties in smart multifunctional materials and multichannel sensors is promising.However,it is challenging to build a strong coupling between SCO a... The utilization of spin crossover(SCO)to modulate the luminescence properties in smart multifunctional materials and multichannel sensors is promising.However,it is challenging to build a strong coupling between SCO and luminescence in one system.Herein,we present a mononuclear compound[Fe(tpe-abpt)_(2)(SeCN)_(2)]·4DMF(1·4DMF,tpe-abpt:(4-(1,1,2,2-tetraphenylethene))-N-(3,5-bis(pyridin-2-yl)-4H-1,2,4-triazol-4yl)methanimine)showing aggregation-induced emission(AIE)and thermally induced SCO properties.Variable-temperature single-crystal structural analysis reveals that SCO changes the number of pathways and strength of intermolecular interactions,resulting in deactivation of nonradiative decay and significant enhancement of luminescence.The photoluminescence(PL)intensity of 1·4DMF exhibited a fivefold increase upon the spin transition from the low-spin to the high-spin states.In contrast with the current strategy of controlling the Förster resonance energy transfer(FRET)process by utilizing SCO to tune the overlap degree between the emission band of the luminophore and UV–vis absorption band of high-spin and low-spin states,we developed a new approach to tune the intermolecular interactions between AIE luminogens(AIEgens)by utilizing a subtle SCO-induced structural transformation,therefore leading to effective coupling between SCO and luminescence and a significant change in luminescence upon SCO.Our results provide a rational strategy to build smartmultifunctionalizedmaterials with remarkably synergetic SCO and luminescence. 展开更多
关键词 spin crossover aggregation-induced emission synergetic property intermolecular interactions switchable materials
原文传递
Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans 被引量:4
12
作者 rui-xia Xu Yan Zhang +12 位作者 yuan-Lin Guo Chun-Yan Ma Yu-Hong Yao Sha Li xiao-Lin Li Ping Qing Ying Gao Na-Qiong Wu Cheng-Gang Zhu Geng Liu Qian Dong Jing Sun Jian-Jun Li 《Chronic Diseases and Translational Medicine》 CSCD 2018年第2期117-126,共10页
Background: Previous studies have clearly demonstrated that XueZhiKang (XZK), an extract of cholestin, can decrease low-density lipoprotein cholesterol (LDL-C) and cardiovascular events. However, the mechanism of the ... Background: Previous studies have clearly demonstrated that XueZhiKang (XZK), an extract of cholestin, can decrease low-density lipoprotein cholesterol (LDL-C) and cardiovascular events. However, the mechanism of the effects of XZK on athero-sclerosis (AS) in humans has been reported less frequently. In the present study, we investigated the impact of XZK on lipoprotein subfractions, oxidized LDL (oxLDL), and interleukin-6 (IL-6). Methods: From October 2015 to July 2016, 40 subjects were enrolled in this study. Of them, 20 subjects with dyslipidemia received XZK 1200 mg/day for 8 weeks (XZK group); 20 additional healthy subjects who did not receive therapy acted as controls. The plasma lipoprotein subfractions, oxLDL, and IL-6 were examined at baseline and again at 8 weeks. Results: Data showed that XZK could significantly decrease not only plasma LDL-C levels (87.26 ± 24.45 vs. 123.34 ± 23.99, P<0.001), total cholesterol (4.14 ± 0.87 vs. 5.08 ± 1.03, P<0.001), triglycerides (0.95 ± 0.38 vs. 1.55 ± 0.61, P<0.05), and apolipoprotein B (1.70 ± 0.35 vs. 1.81 ± 0.72, P<0.05), but also oxLDL (36.36 ± 5.31 vs. 49.20 ± 15.01, P<0.05) and IL-6 (8.50 ± 7.40 vs. 10.40 ± 9.49, P<0.05). At the same time, XZK reduced the concentration of small LDL-C (1.78 ± 2.17 vs. 6.33 ± 7.78, P<0.05) and the percentage of the small LDL subfraction (1.09 ± 1.12 vs. 3.07 ± 3.09, P<0.05). Conclusions: Treatment with 1200 mg/day XZK for 8 weeks significantly decreased the atherogenic small LDL subfraction and reduced oxidative stress and inflammatory markers, in addition to affecting the lipid profile, suggesting multiple beneficial effects in coronary artery disease. 展开更多
关键词 XueZhiKang HYPERLIPIDEMIA LOW-DENSITY LIPOPROTEIN cholesterol SUBFRACTION Oxidized LDL INTERLEUKIN-6
原文传递
Effects of Pitavastatin on Lipoprotein Subfractions and Oxidized Low-density Lipoprotein in Patients with Atherosclerosis 被引量:4
13
作者 rui-xia XU Yan ZHANG +6 位作者 Yue ZHANG Ya-ru WU xiao-lin LI yuan-lin GUO Geng LIU Qian DONG Jian-jun LI 《Current Medical Science》 SCIE CAS 2020年第5期879-884,共6页
It has been demonstrated that pitavastatin can significantly reduce low-density lipoprotein(LDL)cholesterol(LDL-C),but its impact on lipoprotein subfractions and oxidized low-density lipoprotein(oxLDL)has not been det... It has been demonstrated that pitavastatin can significantly reduce low-density lipoprotein(LDL)cholesterol(LDL-C),but its impact on lipoprotein subfractions and oxidized low-density lipoprotein(oxLDL)has not been determined.The aim of the present study was to investigate the potential effects of pitavastatin on subfractions of LDL and high-density lipoprotein(HDL)as well as oxLDL in untreated patients with coronary atherosclerosis(AS).Thirty-six subjects were enrolled in this study.O f them,18 patients with AS were administered pitavastatin 2 mg/day for 8 weeks and 18 healthy subjects without therapy served as controls.The plasma lipid profile,lipoprotein subfractions and circulating oxLDL were determined at baseline and 8 weeks respectively.The results showed that pitavastatin treatment indeed not only decreased LDL-C,total cholesterol(TC),triglycerides(TG)and apolipoprotein B(ApoB)levels,and increased HDL cholesterol(HDL-C),but also reduced the cholesterol concentration of all of the LDL subfractions and the percentage of intermediate and small LDL subfractions.Meanwhile,pitavastatin could decrease plasma oxLDL levels.Furthermore,a more close correlation was found between oxLDL and LDL-C as well as LDL subfractions after pitavastatin treatment.We concluded that a moderate dose of pitavastatin therapy not only decreases LDL-C and oxLDL concentrations but also improves LDL subfractions in patients with AS. 展开更多
关键词 PITAVASTATIN ATHEROSCLEROSIS lipoprotein subfraction low-density lipoprotein
下载PDF
高密度脂蛋白亚组分与高血压的关系 被引量:4
14
作者 刘硕霖 张彦 +9 位作者 李莎 徐瑞霞 郭远林 朱成刚 高莹 董倩 刘庚 孙静 吴娜琼 李建军 《中国循环杂志》 CSCD 北大核心 2018年第9期846-850,共5页
目的:探讨高密度脂蛋白(HDL)亚组分与高血压的关系。方法:连续入选953例患者,并根据有无高血压分为高血压组(n=550)和非高血压组(n=403)。高血压组患者根据降压药物应用情况分为服用药物亚组(n=319,其中单药治疗患者193例,≥2种药物治... 目的:探讨高密度脂蛋白(HDL)亚组分与高血压的关系。方法:连续入选953例患者,并根据有无高血压分为高血压组(n=550)和非高血压组(n=403)。高血压组患者根据降压药物应用情况分为服用药物亚组(n=319,其中单药治疗患者193例,≥2种药物治疗患者126例)和未服用药物亚组(n=231)。应用Lipoprint脂蛋白分类检测仪对HDL颗粒进行分类。分析HDL亚组分与高血压的相关性。结果:高血压组患者的血浆大颗粒高密度脂蛋白胆固醇(HDL-C)水平显著低于非高血压组患者,但其血浆小颗粒HDL-C水平高于非高血压组患者(P均<0.05)。血压控制良好的高血压患者的小颗粒HDL-C水平明显低于血压控制不佳的高血压患者(P<0.05)。多因素Logistic回归模型分析在校正了混杂因素后,大颗粒HDL-C(OR=0.957,95%CI:0.934~0.981,P<0.001)与高血压患病呈负相关,而小颗粒HDL(OR=1.047,95%CI:1.020~1.074,P<0.001)与高血压患病呈正相关。在高血压组患者中,无论是单因素还是多因素Logistic回归分析,各种HDL亚组分与冠心病均不相关(P>0.05)。结论:HDL亚组分受血压的影响,高血压患者大颗粒HDL-C水平降低。高血压不利于大颗粒HDL对心血管的保护作用。 展开更多
关键词 高血压 脂蛋白 冠心病
下载PDF
Research on New Media Marketing Strategy of Quzhou Jianglang Mountain Scenic Spot Based on 4R Marketing Theory
15
作者 XU rui-xia yuan Zhi-qian 《Sino-US English Teaching》 2023年第8期326-333,共8页
With the increasing popularity of new media,new media marketing plays an increasingly important role in the marketing of tourism scenic spots,bringing a new marketing opportunity to tourism scenic spots.Based on the 4... With the increasing popularity of new media,new media marketing plays an increasingly important role in the marketing of tourism scenic spots,bringing a new marketing opportunity to tourism scenic spots.Based on the 4R theory in marketing theory,this paper takes Quzhou Jianglang Mountain as the research object and finds that the following problems exist in the new media marketing of Quzhou Jianglang Mountain:1.The new media users are not closely enough connected;2.the response to the new media market changes is not fast enough;3.the new media marketing relationship interaction is not timely enough;and 4.the return of new media marketing is not ideal.The new media marketing strategy of Quzhou Jianglang Mountain Scenic Spot is proposed from four perspectives:association,reaction,relationship,and return.Finally,the research on the new media marketing strategy of Quzhou Jianglang Mountain Scenic Spot based on the 4R theory is summarized. 展开更多
关键词 4R theory Quzhou Jianglang Mountain Scenic Spot new media marketing
下载PDF
蜡样芽孢杆菌中甲酸脱氢酶基因产氢研究 被引量:4
16
作者 王海燕 郝瑞霞 +4 位作者 赵雅琪 刘伟 程水源 王冕超 徐岚婷 《中国环境科学》 EI CAS CSSCI CSCD 北大核心 2018年第2期729-736,共8页
通过基因筛选,成功分离并克隆到蜡样芽胞杆菌XN12(Bacillus cereus XN12)的甲酸脱氢酶基因fdh F(formate dehydrogenase),该基因全长2937bp,GC含量39.3%,编码978个氨基酸,与已报道的蜡样芽孢杆菌Q1的fdh F基因(Gen Bank No.CP000227.1)... 通过基因筛选,成功分离并克隆到蜡样芽胞杆菌XN12(Bacillus cereus XN12)的甲酸脱氢酶基因fdh F(formate dehydrogenase),该基因全长2937bp,GC含量39.3%,编码978个氨基酸,与已报道的蜡样芽孢杆菌Q1的fdh F基因(Gen Bank No.CP000227.1)同源性达到100%.将其连接在表达载体p ET32a上并融合His标签,构建了重组质粒p ET32a-FDHF-His,转入大肠杆菌BL21(Escherichia coli BL21)后获得了高效表达.重组菌株经IPTG诱导后经Western Blot分析表明,重组蛋白分子量约为108k Da.通过对重组菌株产氢性能试验表明,重组菌对提高产氢率具有一定促进作用,产氢量为每消耗1mol的葡萄糖和甲酸盐分别能产生0.73mol和0.20mol的氢气. 展开更多
关键词 甲酸脱氢酶基因(fdhF) 蜡样芽胞杆菌(Bacilluscereus) 产氢细菌 生物制氢
下载PDF
A PRELIMINARY STUDY ON THE 3DVAR ASSIMILATION OF THE AMSU-A DATA IN SPACE-TIME MULTISCALE ANALYSIS SYSTEM 被引量:3
17
作者 LIU rui-xia XIE yuan-fu LIU Jie 《Journal of Tropical Meteorology》 SCIE 2017年第3期314-322,共9页
Assimilating satellite radiances into Numerical Weather Prediction(NWP) models has become an important approach to increase the accuracy of numerical weather forecasting. In this study, the assimilation technique sche... Assimilating satellite radiances into Numerical Weather Prediction(NWP) models has become an important approach to increase the accuracy of numerical weather forecasting. In this study, the assimilation technique scheme was employed in NOAA's STMAS(Space-Time Multiscale Analysis System) to assimilate AMSU-A radiances data.Channel selection sensitivity experiments were conducted on assimilated satellite data in the first place. Then, real case analysis of AMSU-A data assimilation was performed. The analysis results showed that, following assimilating of AMSU-A channels 5-11 in STMAS, the objective function quickly converged, and the channel vertical response was consistent with the AMSU-A weighting function distribution, which suggests that the channels can be used in the assimilation of satellite data in STMAS. With the case of the Typhoon Morakot in Taiwan Island in August 2009 as an example, experiments on assimilated and unassimilated AMSU-A radiances data were designed to analyze the impact of the assimilation of satellite data on STMAS. The results demonstrated that assimilation of AMSU-A data provided more accurate prediction of the precipitation region and intensity, and especially, it improved the 0-6h precipitation forecast significantly. 展开更多
关键词 MULTIGRID 3DVAR space-time multiscale analysis system numerical experiments
下载PDF
基于极性有机化合物整合采样器的水环境有机污染物测定 被引量:3
18
作者 王立阳 刘瑞霞 +3 位作者 袁鹏 刘晓玲 周友亚 高红杰 《环境工程》 CAS CSCD 北大核心 2021年第5期204-216,224,共14页
作为一种被动采样技术,极性有机化合物整合采样器(polar organic chemical integrative sampler,POCIS)具有安全、易使用、可进行低浓度监测、高回收率和抗生物污染等优点,由于POCIS可以测定极性有机化学物质的时间加权平均(time-weight... 作为一种被动采样技术,极性有机化合物整合采样器(polar organic chemical integrative sampler,POCIS)具有安全、易使用、可进行低浓度监测、高回收率和抗生物污染等优点,由于POCIS可以测定极性有机化学物质的时间加权平均(time-weighted average,TWA)浓度,能够更为全面地反映污染物的长期影响。近年来POCIS已被广泛应用于水环境中农药、药品、内分泌干扰物等有机污染物的分离和富集,以及新兴痕量有机污染物的环境行为和生态风险的评价。介绍了POCIS的结构、原理和校准方法,综述了该装置在水环境中不同类型有机污染物监测中的应用,结合装置特点和实际应用,提出了POCIS在实际环境中需要解决的问题和后续进一步改进的方向。 展开更多
关键词 被动采样 POCIS 水环境 有机污染物监测 取样速率
原文传递
短期低剂量阿托伐他汀对低密度脂蛋白和高密度脂蛋白亚组分的影响 被引量:3
19
作者 姚雨宏 徐瑞霞 +4 位作者 马春艳 郭远林 李小林 李莎 李建军 《中国分子心脏病学杂志》 CAS 2018年第1期2348-2351,共4页
目的研究低剂量阿托伐他汀对动脉粥样硬化患者高密度脂蛋白(HDL)和低密度脂蛋白(LDL)亚组分的影响。方法入选37例动脉粥样硬化患者,随机分为两组:阿托伐他汀10 mg治疗组(n=17例)和阿托伐他汀20mg治疗组(n=20),分别给予10 mg/d和20 mg/d... 目的研究低剂量阿托伐他汀对动脉粥样硬化患者高密度脂蛋白(HDL)和低密度脂蛋白(LDL)亚组分的影响。方法入选37例动脉粥样硬化患者,随机分为两组:阿托伐他汀10 mg治疗组(n=17例)和阿托伐他汀20mg治疗组(n=20),分别给予10 mg/d和20 mg/d阿托伐他汀治疗8周。另入选15名健康受试者作为对照组。Lipoprint脂蛋白分类检测仪对HDL和LDL颗粒进行分类。治疗8周后比较三组治疗前后血脂指标、HDL和LDL颗粒的变化,分析10 mg/d阿托伐他汀和20mg/d阿托伐他汀治疗对LDL和HDL颗粒的影响。结果动脉粥样硬化患者经阿托伐他汀(10 mg/d和20 mg/d)治疗8周后,血浆LDL-C浓度、LDL各亚组分胆固醇浓度及百分比均显著降低。动脉粥样硬化患者经20mg/d的阿托伐他汀治疗8周后,大颗粒HDL-C浓度及百分比显著升高,小颗粒HDL-C浓度及百分比显著降低。结论低剂量阿托伐他汀短期治疗即可显著改善LDL和HDL的亚组分分布,使其向动脉粥样硬化逆转的有益表型转变。 展开更多
关键词 动脉粥样硬化 阿托伐他汀 高密度脂蛋白亚组分 低密度脂蛋白颗粒大小 低密度脂蛋白亚组分
原文传递
右美托咪定作为佐剂用于肝癌手术患者腹横肌平面阻滞的效果评估 被引量:2
20
作者 黄海明 陈瑞霞 +1 位作者 袁圆 叶西就 《岭南现代临床外科》 2020年第5期614-618,共5页
目的评估右美托咪定作为佐剂用于肝癌手术患者腹横肌平面(TAP)阻滞的临床效果。方法选择择期行开腹肝癌切除术患者60例,根据局麻药液中右美托咪定剂量的大小,随机分为R、D0.5和D1.0三组,每组20例。所有患者均在局麻下行超声引导双侧肋缘... 目的评估右美托咪定作为佐剂用于肝癌手术患者腹横肌平面(TAP)阻滞的临床效果。方法选择择期行开腹肝癌切除术患者60例,根据局麻药液中右美托咪定剂量的大小,随机分为R、D0.5和D1.0三组,每组20例。所有患者均在局麻下行超声引导双侧肋缘下TAP阻滞,R组注入0.5%罗哌卡因40 mL,D0.5组注入等量的局麻药和右美托咪定0.5μg/kg,D1.0组注入等量的局麻药和右美托咪定1.0μg/kg。观察TAP阻滞的起效时间、持续时间、患者意识深度(NI)和血流动力学的变化,记录术后苏醒速度、镇痛药用量和并发症的发生情况。结果R、D0.5、D1.0三组TAP阻滞的起效时间分别为13.1±2.9 min、11.6±2.3 min、7.7±2.1 min,持续时间分别为10.7±3.0 h、13.6±3.1 h、17.3±4.2 h,以上指标组间两两比较有统计学差异(P<0.05)。TAP阻滞后,三组的NI、平均动脉压和心率的变化趋势一致:D1.0组<D0.5组<R组(P<0.05);但三组的术后苏醒速度无统计学差异。D1.0组术后48小时内的镇痛药用量少于D0.5组和R组(P<0.05),D0.5组和R组之间无统计学差异。所有患者均未发生TAP阻滞相关并发症。结论右美托咪定与局麻药混合后用于TAP阻滞能加快起效和延长作用时间,同时通过右美托咪定的缓慢吸收入血而发挥镇静和稳定循环的作用。 展开更多
关键词 肝癌手术 TAP阻滞 临床效果 右美托咪定
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部